| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.29 | 4e-06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 7e-05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |